tomkindlon, Risks of digestive diseases in #longCOVID: evidence from a population-based cohort study
“we found even in people with mild #COVID19 symptoms who did not receive hospitalization treatment, the risks of GI dysfunction, #PUD, #GERD, & #NAFLD were evident, while the risks of severe liver disease, IBD, & biliopancreatic diseases were not”
@longcovid
#PwLC #LC #postcovid @covid19
#COVID #SARSCoV2 @novid #novid #CovidIsNotOver @auscovid19
Add comment